97
Participants
Start Date
October 2, 2024
Primary Completion Date
March 10, 2025
Study Completion Date
March 10, 2025
Gepotidacin
Gepotidacin will be administered.
GSK Investigational Site, Morgantown
GSK Investigational Site, Kingwood
GSK Investigational Site, Miami
GSK Investigational Site, Palm Springs
GSK Investigational Site, Dayton
GSK Investigational Site, Mesquite
GSK Investigational Site, Houston
GSK Investigational Site, Houston
GSK Investigational Site, Valencia
GSK Investigational Site, Modesto
GSK Investigational Site, Pasadena
GSK Investigational Site, San Diego
GSK Investigational Site, Ormond Beach
GSK Investigational Site, Palm Springs
GSK Investigational Site, Plant City
GSK Investigational Site, Sweetwater
GSK Investigational Site, West Palm Beach
GSK Investigational Site, West New York
GSK Investigational Site, New York
GSK Investigational Site, Forney
GSK Investigational Site, Missouri City
GSK Investigational Site, Bountiful
Lead Sponsor
GlaxoSmithKline
INDUSTRY